Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. 1991

E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
Département de Pharmacologie Périnatale et Pédiatrique, Hôpital Saint-Vincent de Paul, Paris, France.

Twelve children 1-5 y old were randomly assigned to receive midazolam 0.2 mg.kg-1 either by the intravenous (IV) or intranasal (IN) routes. After IN administration the rapid onset of absorption was observed (tmax 12 min). After both routes of administration the half-life was similar (2.2 h IN and 2.4 h IV). After IN administration the apparent plasma clearance and volume of distribution were about twice as high as after IV administration. The results are consistent with an estimated mean bioavailability of 55%.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
August 1997, Journal of clinical pharmacology,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
September 1998, British journal of clinical pharmacology,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
December 1995, Acta paediatrica (Oslo, Norway : 1992),
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
November 2006, Indian journal of pediatrics,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
April 1988, British journal of clinical pharmacology,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
November 2013, Equine veterinary journal,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
January 2005, Anesthesia progress,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
February 1991, Anesthesiology,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
September 2002, Biopharmaceutics & drug disposition,
E Rey, and L Delaunay, and G Pons, and I Murat, and M O Richard, and C Saint-Maurice, and G Olive
February 2013, American journal of veterinary research,
Copied contents to your clipboard!